Could the new EU Medical Devices Regulation put the UK MedTech industry in peril?

There has been much debate in recent years about the difficulty in attracting both private and public funds into the UK biotech industry.  At certain points, it seemed like a disproportionate percentage of the funding that was invested into UK biotech came from the US.  It is likely that there...

Read more

UK Supreme Court judgment in long-running dispute between Eli Lilly and Actavis on the combination therapy pemetrexed + vitamin B12 results in significant outcomes for patent infringement in the UK

In a judgment issued on 12 July, the UK Supreme Court made some significant changes in the law of UK patent infringement which could have far reaching consequences, especially in the pharmaceutical sector. In particular, they addressed the issue of infringement by equivalents not otherwise falling within the literal claim scope and...

Read more